Pharmaceutial and Medical Device Law, published by the ABA Health Law Section and Bloomberg BNA, provides readers with an overview of key legal and regulatory issues that impact the development and marketing activities of pharmaceutical and medical device companies.

Carol Poindexter, Paul Sumilas and Vijay Rao have contributed to Chapter 8 (Federal Sentencing Guidelines and Compliance Measures), which covers topics such as

  • How to structure and manage compliance programs to meet government regulator expectations.
  • Strategies for managing investigations and navigating disclosure issues.
  • Potential individual liability for the board of directors and senior management.
  • Standards and best practices for compliance as set of forth in industry guidance.


Practice area:

Recent publications

M&A Outlook 2025 Crop 5

Publication

Why digital transformation is expected to drive M&A

The industry-wide shift towards digital transformation, fueled by AI-driven innovations dominating the market, is likely to advance dealmaking in 2025.

Global | March 14, 2025

Corporate, M&A and securities
London skyscrapers

Publication

Essential Corporate News – Week ending 14 March 2025

On 12 March 2025, Companies House updated its outline transition plan in relation to the changes being introduced to Companies House by the Economic Crime and Corporate Transparency Act 2023 (ECCTA).

United Kingdom | March 14, 2025

Corporate, M&A and securities
Technology-security-concept

Publication

Does the Privacy Act apply to your NFP? The answer might surprise you

For charities and not-for-profit organisations (NFPs) in Australia, understanding and complying with privacy obligations is important for maintaining trust with donors, beneficiaries and the public.

Australia | March 14, 2025

Technology
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now